Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Market Morning Digest SpaceX IPO Speculation Nvidia Earnings and Bezos on AI Bubble Bitcoin Ethereum Continue Decline Amid 400M Liquidations Macro and Geopolitical Headwinds Persist Bruno Mars Ties Taylor Swifts Radio Songs Record with 22nd Top 10 Hit Risk It All Healthcare and Tech Boost SP 500 to Fresh Highs Communication Services Slips Shells Capital Return Strategy Faces Renewed Market Scrutiny PONY Q1 2026 Earnings EPS Beats Estimates as Autonomous Driving Milestones Accelerate FHN Q1 2026 Earnings EPS Beats Estimates by Over 6 Satellos Bioscience Inc MSLE Q1 2026 Earnings EPS Beat with 1358 Surprise Stock Declines 546 Scilex Holding SCLX Q1 2026 Earnings Reported EPS of 476 Stock Rises Over 6 Amid No Revenue Cass Information Systems Q1 2026 Earnings EPS Beat by Nearly 6 but Stock Slips on Missing Revenue Details GEN Restaurant Group Inc GENK Drops 224 as Shares Approach Critical Support Entergy Louisiana Bond ELC Holds Steady Near 2032 as Yield Environment Shifts Dr Reddys Labs RDY Edges Higher Testing Key Resistance Levels Meridian Holdings Inc MRDN Edges Higher Testing Key Resistance Levels Consumer Credit Growth Surges in December Signaling Robust Spending VanEck ETF Inflows Surge Nearly 1 Billion in Latest League Table Data Trump Signals Firm Stance on Iran Maintains Naval Blockade Until Deal Reached White House and China Offer Contrasting Views on Trade Deals Following TrumpXi Summit Newton Golf Company Inc NWTG Q1 2026 Earnings Wider Loss as PreRevenue Company Misses Estimates Teradyne Q1 2026 Earnings EPS Surges Past Estimates on Strong Demand GASS Q4 2025 Earnings EPS Beat of 417 Highlights Operational Efficiency Amid Market Headwinds OptimizeRx OPRX Q1 2026 Earnings Massive EPS Beat Sends Stock Higher Two Harbors Investments Corp TWOD Q1 2026 Earnings EPS Surges Past Estimates in Resilient Quarter MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline